Company news

Royalty Pharma plc news in 2022

Royalty Pharma plc's news releases, calls and decks from 2022, newest first.

View company

Royalty Pharma Announces Expansion of Senior Leadership Team

December 14, 2022

Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference

November 27, 2022

Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones

November 8, 2022

Royalty Pharma Reports Third Quarter 2022 Results

November 7, 2022

Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022

October 17, 2022

Royalty Pharma Declares Fourth Quarter 2022 Dividend

October 16, 2022

Royalty Pharma Announces R&D Funding Collaboration With Merck

October 11, 2022

Royalty Pharma Announces Expansion of Leadership Team

October 11, 2022

Royalty Pharma Reports Second Quarter 2022 Results

August 3, 2022

Royalty Pharma Declares Third Quarter 2022 Dividend

July 14, 2022

Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022

July 13, 2022

Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million

July 12, 2022

Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million

June 29, 2022

Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

June 7, 2022

Royalty Pharma to Present at the UBS Global Healthcare Conference 2022

May 22, 2022

Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders

May 16, 2022

Royalty Pharma Reports First Quarter 2022 Results

May 4, 2022

Royalty Pharma Declares Second Quarter 2022 Dividend

April 17, 2022

Royalty Pharma to Announce First Quarter 2022 Financial Results on May 5, 2022

April 12, 2022

Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment

March 28, 2022

Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference

March 2, 2022

Royalty Pharma Announces Inaugural Investor Day

February 15, 2022

Royalty Pharma Reports Q4 and Full Year 2021 Results

February 14, 2022

Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on February 15, 2022

January 19, 2022

Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan Healthcare Conference

January 9, 2022

Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million

January 6, 2022

Cytokinetics and Royalty Pharma Announce Funding Agreements Totaling up to $450 Million

January 6, 2022

Royalty Pharma Announces 12% Dividend Increase

January 5, 2022

Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 10

January 4, 2022

Calls in 2022

Decks in 2022